We are live on ! Find out more
KANG

iKang Healthcare Group, Inc.
KANG

Delisted

KANG was delisted on the 18th of January, 2019.

67 hedge funds and large institutions have $564M invested in iKang Healthcare Group, Inc. in 2015 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

960% more call options, than puts

Call options by funds: $27.7M | Put options by funds: $2.61M

40% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 20

26% more capital invested

Capital invested by funds: $447M → $564M (+$117M)

21% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 14

10% more funds holding

Funds holding: 6167 (+6)

14% less funds holding in top 10

Funds holding in top 10: 76 (-1)

Holders
67
Holders Change
+6
Holders Change %
+9.84%
% of All Funds
1.76%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.16%
New
28
Increased
17
Reduced
14
Closed
20
Calls
$27.7M
Puts
$2.61M
Net Calls
+$25M
Net Calls Change
+$25.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$159M +$31.4K +1,818 +0%
Wellington Management Group
2
Wellington Management Group
Massachusetts
$98.4M +$4.24M +245,794 +5%
SC
3
Sculptor Capital
New York
$54.1M +$32.1M +1,857,745 +236%
FI
4
Fosun International
China
$44.6M -$11.7M -679,097 -24%
SIM
5
Summitview Investment Management
Cayman Islands
$25.5M +$21.5M +1,248,299 New
ASI
6
All-Stars Investment
Hong Kong
$17.4M
HSBC Holdings
7
HSBC Holdings
United Kingdom
$17.4M +$14.7M +850,447 New
JP Morgan Chase
8
JP Morgan Chase
New York
$17.1M -$29.8M -1,724,605 -67%
Citigroup
9
Citigroup
New York
$11.7M +$7.29M +422,174 +284%
PRCM
10
Pine River Capital Management
Minnesota
$11.3M -$10.3M -599,274 -52%
OAM
11
Oberweis Asset Management
Illinois
$9.72M -$6.09M -352,970 -43%
VAM
12
Visium Asset Management
New York
$9.21M +$2.87M +166,332 +59%
Fidelity International
13
Fidelity International
Bermuda
$8.4M -$4.62M -267,689 -39%
Deutsche Bank
14
Deutsche Bank
Germany
$6.34M +$4.67M +270,548 +678%
Morgan Stanley
15
Morgan Stanley
New York
$6.16M +$3.29M +190,409 +172%
AG
16
Ashmore Group
United Kingdom
$5.46M
First Manhattan
17
First Manhattan
New York
$5.3M +$4.48M +259,578 New
CS
18
Credit Suisse
Switzerland
$4.89M -$95.3K -5,525 -2%
JAM
19
Jupiter Asset Management
United Kingdom
$4.28M
Barclays
20
Barclays
United Kingdom
$3.9M -$88.8K -5,146 -3%
BNP Paribas Financial Markets
21
BNP Paribas Financial Markets
France
$3.4M +$1.43M +83,054 +100%
AGA
22
Altrinsic Global Advisors
Connecticut
$3.06M -$690K -40,000 -21%
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$2.83M +$2.12M +122,703 +792%
Mirae Asset Global Investments
24
Mirae Asset Global Investments
South Korea
$2.54M +$204K +11,800 +11%
SG Americas Securities
25
SG Americas Securities
New York
$2.45M +$2.07M +119,974 New

KANG Hedge Fund Activity: Q4 2015 in Review

67 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q4 2015, worth a combined $564M — up 26% from $447M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new KANG positions and 20 closed out — a net gain of 8 holders — while 17 added to existing stakes and 14 trimmed.

The largest buyer was Sculptor Capital, adding an estimated $32.1M. The largest seller was JP Morgan Chase, cutting an estimated $29.8M.

  • 67 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q4 2015, up from 61 in Q3 2015.
  • Funds reported $564M of iKang Healthcare Group, Inc. stock for Q4 2015, up 26% quarter-over-quarter.
  • 28 funds opened new iKang Healthcare Group, Inc. positions in Q4 2015 and 20 closed out, a net change of +8 holders.
  • The largest iKang Healthcare Group, Inc. buyer in Q4 2015 was Sculptor Capital, an estimated $32.1M added.
  • The largest iKang Healthcare Group, Inc. seller in Q4 2015 was JP Morgan Chase, an estimated $29.8M sold.

Based on aggregated 13F filings for Q4 2015.